Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Gains from Investment Securities (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Gains from Investment Securities for 4 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 6941.12% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $5.7 million for FY2025, 39.64% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $5.7 million at Century Therapeutics, up from $4.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $6.8 million in Q2 2025, with the low at -$84000.0 in Q4 2024.
  • Average Gains from Investment Securities over 4 years is $2.7 million, with a median of $2.4 million recorded in 2022.
  • The sharpest move saw Gains from Investment Securities soared 12022.81% in 2023, then tumbled 107.92% in 2024.
  • Over 4 years, Gains from Investment Securities stood at $5.8 million in 2022, then plummeted by 81.66% to $1.1 million in 2023, then tumbled by 107.92% to -$84000.0 in 2024, then surged by 6941.12% to $5.7 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $5.7 million, $4.0 million, and $6.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.